The BellPotter research note suggests the following dates/milestones.
The terms of news flow over the next 12 months, we expect the following:
• December 2015 -Top-line results from Phase II Fragile X Syndrome trial;
• 4QCY15 -Top-line results from INTREPID Traumatic Brain Injury (TBI) trial;
• End CY15/1Q16 – Initiation of paediatric Rett Syndrome Trial; • 1QCY16 - Top-line results from Phase II concussion trial;
• 2HCY16 – Top-line results from paediatric Rett Syndrome Trial; • 2HCY16 – Potential licensing deal for trofinetide (all indications)
Although everything I have read from the company seems to point at Second Half of the year 2015 for the TBI/Intrepid results. Maybe B.P were just being conservative with the dates - is there anything to suggest these timelines are more accurate, for now I will assume that we are awaiting news for this from anytime now to the end of the year.
If we get positive top line results in either it is really game on. (This isn't even including the FX results) which I believe were even more promising than Retts in Animal Trials.
** Again correct me if I am wrong.
Screaming Buy?, page-17
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$16.57 |
Change
2.170(15.1%) |
Mkt cap ! $2.117B | |||
| Open | High | Low | Value | Volume |
| $14.85 | $16.67 | $14.60 | $24.77M | 1.544M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1500 | $16.52 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $16.57 | 1717 | 1 |
View Market Depth
| Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |